Dr. Darush Rahmani, Rheumatologist at ARC Round Rock, talks about infusion therapy for active inflammatory arthritis in this recent podcast.
Dr. Norman H. Chenven, Founding CEO of Austin Regional Clinic, was the guest speaker at the June 14 Manor Chamber of Commerce luncheon.
Many thanks to The Dudley & Bob + Matt Show on KLBJ for their kind remarks about Dr. Christopher W. Bailey and ARC.
Our patients rely on ARC Access for a lifetime of care. Watch how ARC Access has made a difference in Talya’s life. She has had more than her share of soccer injuries and relies on her team of ARC doctors to help return her to health and the soccer field. “The doctors at ARC have been extremely, extraordinarily, super helpful in treating my soccer injuries,” Talya says. “I always end up back on the field.”
Taking your child to the doctor when he or she is healthy is just as important as going to the doctor for an illness. A well-check exam focuses on maintaining your child’s health and allows for preventive care. To book a well-check exam for your child, book an appointment online.
Thanks to your feedback we are making the payment experience friendlier and easier for you. Starting July 1st, we’re implementing changes to improve customer service, convenience, and access.
ARC is joining forces with Premier Physicians to honor inspirational 60 somethings by featuring them in the 2019 Austin 60 Strong calendar. Nominate someone at Austin60Strong.com. Connected Senior Care Advantage by ARC and Premier Physicians is sponsoring the Austin 60 Strong contest.
You love our online booking and have told us you want more. So we’ve added new specialists and have more options coming soon. We are also making it easier for you to access bone density exams and life-saving screenings like mammograms in South Austin.
Our patients rely on ARC Access for a lifetime of connected care. Watch how it has made a difference in their lives. Meet Talya.
ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.